ESC 365 - Glycemic control with ipragliflozin, a novel selective SGLT2 inhibitor, ameliorated endothelial dysfunction in obese and non-obese diabetic mice.

ESC Premium Access

Glycemic control with ipragliflozin, a novel selective SGLT2 inhibitor, ameliorated endothelial dysfunction in obese and non-obese diabetic mice.

Session: Vascular biology

Topic: Endothelial function

Speaker: Doctor H. Salim (Surabaya, ID)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Hotimah Masdan Salim

University of Nahdlatul Ulama Surabaya, Surabaya (Indonesia)

0 follower

6 more presentations in this session

Myeloid cell specific alpha1-AMPK deletion induces a proinflammatory phenotype and enhances angiotensin II-mediated vascular dysfunction

Speaker: Doctor T. Jansen (Mainz, DE)

Endothelial PGC-1alpha preserves endothelial function during chronic angiotensin II treatment by maintaining eNOS expression, reducing vascular oxidative stress and supporting the antioxidant defense

Speaker: Doctor T. Jansen (Mainz, DE)

Impact of the adiponectin paralog CTRP13 on endothelial cells

Speaker: Doctor M. Aslam (Giessen, DE)

Monocyte-platelet aggregates associated with CD14++CD16+ monocytes predict diffuse coronary artery disease: relationship to microvascular function

Speaker: Doctor R. Brown (Newcastle-Upon-Tyne, GB)

A direct thrombin inhibitor paradoxically enhances thrombin generation via suppression of protein C activation and factor Va degradation in human plasma

Speaker: Doctor Y. Morishima (Tokyo, JP)

Access the full session

Vascular biology

Speakers: Doctor H. Salim, Doctor T. Jansen, Doctor T. Jansen, Doctor M. Aslam, Doctor R. Brown...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources